Wells Fargo’s Lux Health Tech Acquisition Corp. Units LUXAU Stock Holding History

Wells Fargo’s Portfolio LUXAU Stock Details LUXAU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-600	Closed	-$6K	–	7843
2022 Q2	$6K	Hold	600	–	–	﹤0.01%	5974
2022 Q1	$6K	Buy	+600	New	+$5.98K	﹤0.01%	6451

Other funds holding LUXAU

BBR Partners New York $1.79B AUM 16.83% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Wells Fargo's LUXAU Position: Q3 2022 in Review

Wells Fargo sold out of Lux Health Tech Acquisition Corp. Units (LUXAU) in Q3 2022, closing a stake of 600 shares — an estimated $6K sold.

Wells Fargo first reported a position in LUXAU in Q1 2022 and held it in 2 quarters. The position peaked at $6K in Q2 2022. 9 funds tracked by Wall St. Rank hold LUXAU as of Q3 2022.

Wells Fargo reported no remaining Lux Health Tech Acquisition Corp. Units position as of Q3 2022 after selling out during the quarter.
Wells Fargo sold 600 Lux Health Tech Acquisition Corp. Units shares in Q3 2022, an estimated $6K.
Wells Fargo first reported a position in Lux Health Tech Acquisition Corp. Units in Q1 2022 and held it in 2 quarters.
Wells Fargo's Lux Health Tech Acquisition Corp. Units position peaked at $6K in Q2 2022.
9 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Units as of Q3 2022.

Based on Wells Fargo's 13F filing for Q3 2022, filed 14 Nov 2022.